Dashboard
Manage Tickers

OPTN OptiNose, Inc.

Nasdaq optinose.com


$ -0.11 (-1.13 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 601.80 $ 0.00 (0 %)
DIA $ 464.13 $ 0.00 (0 %)
SPY $ 665.10 $ 0.00 (0 %)
TLT $ 91.02 $ 0.00 (0 %)
GLD $ 387.88 $ 0.00 (0 %)
$ 9.6
-- x --
-- x --
-- - --
$ 4.82 - $ 20.03
860,961
na
97.22M
$ 0.58
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2025 03-31-2025 10-Q
2 03-26-2025 12-31-2024 10-K
3 11-12-2024 09-30-2024 10-Q
4 08-08-2024 06-30-2024 10-Q
5 05-14-2024 03-31-2024 10-Q
6 03-07-2024 12-31-2023 10-K
7 11-09-2023 09-30-2023 10-Q
8 08-10-2023 06-30-2023 10-Q
9 05-11-2023 03-31-2023 10-Q
10 03-07-2023 12-31-2022 10-K
11 11-10-2022 09-30-2022 10-Q
12 08-11-2022 06-30-2022 10-Q
13 05-12-2022 03-31-2022 10-Q
14 03-08-2022 12-31-2021 10-K
15 11-15-2021 09-30-2021 10-Q
16 08-11-2021 06-30-2021 10-Q
17 05-05-2021 03-31-2021 10-Q
18 03-03-2021 12-31-2020 10-K
19 11-05-2020 09-30-2020 10-Q
20 08-04-2020 06-30-2020 10-Q
21 05-07-2020 03-31-2020 10-Q
22 03-05-2020 12-31-2019 10-K
23 11-12-2019 09-30-2019 10-Q
24 08-12-2019 06-30-2019 10-Q
25 05-09-2019 03-31-2019 10-Q
26 03-06-2019 12-31-2018 10-K
27 11-13-2018 09-30-2018 10-Q
28 08-14-2018 06-30-2018 10-Q
29 05-14-2018 03-31-2018 10-Q
30 03-13-2018 12-31-2017 10-K
31 11-27-2017 09-30-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-neutral-on-optinose-maintains-9-price-target
HC Wainwright & Co. Reiterates Neutral on ...
05/19/2025 10:39:14

HC Wainwright & Co. analyst Matthew Caufield reiterates OptiNose (NASDAQ:OPTN) with a Neutral and maintains $9 price tar...

piper-sandler-downgrades-optinose-to-neutral-lowers-price-target-to-9
Piper Sandler Downgrades OptiNose to Neutr...
03/21/2025 15:26:08

Piper Sandler analyst David Amsellem downgrades OptiNose (NASDAQ:OPTN) from Overweight to Neutral and lowers the price targe...

hc-wainwright--co-downgrades-optinose-to-neutral-lowers-price-target-to-9
HC Wainwright & Co. Downgrades OptiNose to...
03/21/2025 12:14:09

HC Wainwright & Co. analyst Matthew Caufield downgrades OptiNose (NASDAQ:OPTN) from Buy to Neutral and lowers the price ...

lake-street-downgrades-optinose-to-hold-lowers-price-target-to-9
Lake Street Downgrades OptiNose to Hold, L...
03/20/2025 18:39:35

Lake Street analyst Thomas Flaten downgrades OptiNose (NASDAQ:OPTN) from Buy to Hold and lowers the price target from $17 to...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
03/20/2025 17:06:07

crude-oil-gains-over-1-us-weekly-jobless-claims-increase
Crude Oil Gains Over 1%; US Weekly Jobless...
03/20/2025 16:01:03

optinose-stock-is-soaring-today-whats-going-on
OptiNose Stock Is Soaring Today: What's Go...
03/20/2025 13:22:52

OptiNose Inc (NASDAQ:OPTN) shares are trading higher Thursday after Paratek Pharmaceuticals announced a deal to acquire the com...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
03/20/2025 12:09:53

us-stocks-likely-to-open-lower-after-fed-decision-any-pullback-in-equities-offers-an-opportunity-says-expert
US Stocks Likely To Open Lower After Fed D...
03/20/2025 09:53:33

U.S. stock futures rose on Thursday following the Federal Open Market Committee's decision on Wednesday calling inflation &...

reported-earlier-paratek-pharmaceuticals-to-acquire-optinose-in-deal-worth-up-to-330m-including-9-cash-and-potential-5share-in-future-milestones
Reported Earlier, Paratek Pharmaceuticals ...
03/20/2025 06:19:08

Paratek will accelerate access for XHANCE beyond specialists to primary care providers maximizing the recent label expansion fo...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
02/10/2025 12:05:39

optinose-reveals-q4-preliminary-results-registers-revenues-of-224m-is-in-line-with-prior-guidance-and-growth-in-xhance-prescriptions
OptiNose Reveals Q4 Preliminary Results: R...
01/15/2025 12:19:18

hc-wainwright--co-maintains-buy-on-optinose-raises-price-target-to-18
HC Wainwright & Co. Maintains Buy on OptiN...
01/03/2025 11:47:23

HC Wainwright & Co. analyst Matthew Caufield maintains OptiNose (NASDAQ:OPTN) with a Buy and raises the price target fro...

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
12/31/2024 00:50:04

optinose-shares-are-trading-lower-after-the-company-announced-a-1-for-15-reverse-stock-split
OptiNose shares are trading lower after th...
12/26/2024 14:09:46

optinose-plans-to-effect-1-for-15-reverse-stock-split-at-500-pm-eastern-standard-time-on-december-30-2024
Optinose Plans To Effect 1-For-15 Reverse ...
12/26/2024 12:05:40

Beginning with the opening of trading on December 31, 2024, Optinose's common stock will trade on the Nasdaq Global Select ...

piper-sandler-maintains-overweight-on-optinose-lowers-price-target-to-1
Piper Sandler Maintains Overweight on Opti...
11/13/2024 16:59:17

Piper Sandler analyst David Amsellem maintains OptiNose (NASDAQ:OPTN) with a Overweight and lowers the price target from $3 ...

hc-wainwright--co-reiterates-buy-on-optinose-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Opti...
11/13/2024 12:30:25

HC Wainwright & Co. analyst Matthew Caufield reiterates OptiNose (NASDAQ:OPTN) with a Buy and maintains $5 price target.

optinose-expects-2024-xhance-net-revenues-of-75m-79m-compared-to-prior-guidance-of-85m-90m-with-average-net-revenue-per-prescription-to-be-approximately-270-versus-prior-guidance-to-exceed-250
OptiNose Expects 2024 Xhance Net Revenues ...
11/12/2024 12:06:30

Financial GuidanceXHANCE Net Revenue The Company expects XHANCE net revenues for the full year of 2024 to be between $75.0 to $...

optinose-q3-2024-gaap-eps-000-beats-005-estimate-sales-2044m-miss-2300m-estimate
OptiNose Q3 2024 GAAP EPS $0.00 Beats $(0....
11/12/2024 12:01:43

OptiNose (NASDAQ:OPTN) reported quarterly earnings of $0.00 per share which beat the analyst consensus estimate of $(0.05) by 1...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION